The weight loss drug boom isn't over yet — here's what to expect in the year ahead

2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance coverage and unpleasant side...

Related Keywords

France ,North Carolina ,United States ,Denmark ,New York ,Switzerland ,Indiana ,San Diego ,California ,China ,Chinese ,America ,Swiss ,Eli Lilly Zepbound ,Cantor Fitzgerald Chen ,David Ricks ,Albert Bourla ,Inversago Pharma ,Eli Lilly ,Carter Gould ,Guggenheim Fernandez ,Seamus Fernandez ,Eduardo Grunvald ,Cantor Fitzgerald Louise Chen ,Michael Nedelcovych ,Cowen Nedelcovych ,Chris Schott ,Uc San Diego Center ,Amgen ,Morgan Stanley ,Barclays ,Goldman Sachs ,Astrazeneca ,Pfizer ,Novo Nordisk ,Wall Street ,Cantor Fitzgerald ,Louise Chen ,Advanced Weight ,Carmot Therapeutics ,Embark Biotech ,Structure Therapeutics ,News ,